HKD 3.58
(-0.56%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 369.55 Million CNY | 11.67% |
2022 | 324.44 Million CNY | 40.77% |
2021 | 230.1 Million CNY | 2.23% |
2020 | 221.64 Million CNY | 34.77% |
2019 | 168.08 Million CNY | 36.38% |
2018 | 125.09 Million CNY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 132.55 Million CNY | 0.0% |
2024 Q1 | 132.55 Million CNY | 40.23% |
2023 Q3 | 94.52 Million CNY | 16.16% |
2023 FY | - CNY | 11.67% |
2023 Q4 | 94.52 Million CNY | 0.0% |
2023 Q2 | 81.37 Million CNY | 0.0% |
2023 Q1 | 81.37 Million CNY | 1.41% |
2022 Q3 | 80.24 Million CNY | 6.67% |
2022 Q2 | 75.22 Million CNY | 0.0% |
2022 Q1 | 75.22 Million CNY | 54.1% |
2022 FY | - CNY | 40.77% |
2022 Q4 | 80.24 Million CNY | 0.0% |
2021 Q2 | 64.01 Million CNY | 0.0% |
2021 Q1 | 64.01 Million CNY | 4.56% |
2021 Q4 | 48.81 Million CNY | 0.0% |
2021 Q3 | 48.81 Million CNY | -23.74% |
2021 FY | - CNY | 2.23% |
2020 Q1 | 47.54 Million CNY | 0.0% |
2020 Q4 | 61.22 Million CNY | 0.0% |
2020 Q3 | 61.22 Million CNY | 28.76% |
2020 Q2 | 47.54 Million CNY | 0.0% |
2020 FY | - CNY | 34.77% |
2019 FY | - CNY | 36.38% |
2018 FY | - CNY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Wai Chun Bio-Technology Limited | 14.89 Million HKD | -2381.374% |
Lee & Man Chemical Company Limited | 597.01 Million HKD | 38.1% |